43 Plenary Session - The Next Frontier in the Application of Quality by Design

Monday, October 29, 2012: 8:30 AM
Allegheny II (Westin )
Description:
Plenary session on Quality by Design. Invited speakers will address potential new opportunities and challenges in the application of QbD.

Sponsor:
Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
Co-Sponsor(s):
Computing Systems and Technology Division (10), Food, Pharmaceutical & Bioengineering Division (15), Research and New Technology Committee (18j), Process Development Division (12)

Chair:
Salvador García-Muñoz
Email: sal.garcia@lilly.com

Co-Chair:
Huiquan Wu
Email: huiquan.wu@fda.hhs.gov

- indicates paper has an Extended Abstract file available on CD.


8:30 AM
(43a) Looking to the Future in Continuous Pharmaceutical Manufacturing
Richard D. Braatz

9:00 AM
(43b) New Challenges and Opportunities for Pharmaceutical Manufacturing Science
Vincent Vilker and Mansoor A. Khan

9:30 AM
(43c) Recent Advances in the Molecular Modeling Foundation of Systems-Based Pharmaceutics
Constantinos C. Pantelides

10:00 AM
(43d) Experience with Regulatory Issues for Biomedical Devices and Vision for the Use of Advanced Control In Pharmaceutical Operations
Francis J. Doyle III, Eyal Dassau and Howard Zisser
File available
10:30 AM
(43e) Chemical Engineering and Biopharmaceutics: Linking the Process with the Ultimate Quality Attribute
Ravi M. Shanker
See more of this Group/Topical: Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
<< Previous Session | Next Session >>